<p>A) Adult male mice were myeloablated via irradiation and transplanted with female T-cell depleted bone marrow followed by challenge with TRAMP-C2 tumors 10 weeks after transplantation. n = 5 mice/group, results of a single experiment. B) Adult male mice were sublethally irradiated with 6 Gy and challenged intradermally with 1×10<sup>6</sup> TRAMP-C2. The following day, mice received a donor lymphocyte infusion (DLI) of 3×10<sup>7</sup> splenocytes <i>i.v</i>. n = 10 mice/group, one of 3 experiments with similar results. C) Adoptively-transferred CD25+ regulatory T cells do not mediate increased tumor growth seen following male DLI. Mice were irradiated and tumor-challenged as in B, and received splenocytes that were CD25-depleted using m...
<p>Non-transgenic BALB/c and Id-specific TCR-transgenic (Id-TCR) BALB/c mice with (+/+) or without (...
Tumors were eradicated following adoptive immunotherapy of (C57BL/6J X DBA/2J) F1 (B6D2F1) hybrid mi...
Tumors were eradicated following adoptive immunotherapy of (C57BL/6J X DBA/2J) F1 (B6D2F1) hybrid mi...
<p>A) TRAMP-C2 tumor cells grow progressively in adult male mice, with a slower kinetic but complete...
<p>B6-LY5.2/Cr mice were challenged with 3×10<sup>5</sup> B16F0 cells <i>i.d.</i> 6 days later, mice...
Background: In prostate cancer, genes encoding androgen-regulated, Y-chromosome-encoded, and tissue-...
<p>Male skin grafts were transplanted onto females recipients treated or not at days −1, 6 and 13 po...
<p>A total of 1×10<sup>5</sup> B16 cells were injected s.c. in the left flank of C57BL/6 mice. Three...
In prostate cancer, genes encoding androgen-regulated, Y-chromosome-encoded, and tissue-specific ant...
In prostate cancer, genes encoding androgen-regulated, Y-chromosome-encoded, and tissue-specific ant...
In prostate cancer, genes encoding androgen-regulated, Y-chromosome-encoded, and tissue-specific ant...
<p>(A) HLA-A2<sup>+</sup> transgenic mice were vaccinated on days 0, 14, 28 and 42, with 100 µg Mam-...
<p>The minimal tumorigenic dose was given to FVB/N mice on day 0; Cy was given on day 2; vaccine or ...
<p>A) Immunization of females with TRAMP-GMCSF cells produces augmented CD4 responses against DBY an...
<p>B6-LY5.2/Cr mice were challenged with 3×10<sup>5</sup> B16F0 cells <i>i.d.</i> 6 days later, mice...
<p>Non-transgenic BALB/c and Id-specific TCR-transgenic (Id-TCR) BALB/c mice with (+/+) or without (...
Tumors were eradicated following adoptive immunotherapy of (C57BL/6J X DBA/2J) F1 (B6D2F1) hybrid mi...
Tumors were eradicated following adoptive immunotherapy of (C57BL/6J X DBA/2J) F1 (B6D2F1) hybrid mi...
<p>A) TRAMP-C2 tumor cells grow progressively in adult male mice, with a slower kinetic but complete...
<p>B6-LY5.2/Cr mice were challenged with 3×10<sup>5</sup> B16F0 cells <i>i.d.</i> 6 days later, mice...
Background: In prostate cancer, genes encoding androgen-regulated, Y-chromosome-encoded, and tissue-...
<p>Male skin grafts were transplanted onto females recipients treated or not at days −1, 6 and 13 po...
<p>A total of 1×10<sup>5</sup> B16 cells were injected s.c. in the left flank of C57BL/6 mice. Three...
In prostate cancer, genes encoding androgen-regulated, Y-chromosome-encoded, and tissue-specific ant...
In prostate cancer, genes encoding androgen-regulated, Y-chromosome-encoded, and tissue-specific ant...
In prostate cancer, genes encoding androgen-regulated, Y-chromosome-encoded, and tissue-specific ant...
<p>(A) HLA-A2<sup>+</sup> transgenic mice were vaccinated on days 0, 14, 28 and 42, with 100 µg Mam-...
<p>The minimal tumorigenic dose was given to FVB/N mice on day 0; Cy was given on day 2; vaccine or ...
<p>A) Immunization of females with TRAMP-GMCSF cells produces augmented CD4 responses against DBY an...
<p>B6-LY5.2/Cr mice were challenged with 3×10<sup>5</sup> B16F0 cells <i>i.d.</i> 6 days later, mice...
<p>Non-transgenic BALB/c and Id-specific TCR-transgenic (Id-TCR) BALB/c mice with (+/+) or without (...
Tumors were eradicated following adoptive immunotherapy of (C57BL/6J X DBA/2J) F1 (B6D2F1) hybrid mi...
Tumors were eradicated following adoptive immunotherapy of (C57BL/6J X DBA/2J) F1 (B6D2F1) hybrid mi...